Journal of the American Society of Nephrology, Vol 4, 1159-1171, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group

AS Levey, T Greene, MD Schluchter, PA Cleary, PE Teschan, RA Lorenz, ME Molitch, WE Mitch, C Siebert and PM Hall
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

To assess the utility and precision of GFR measurements in multicenter trials, the test performance and variability of GFR were analyzed in 2,250 patients enrolled in 44 clinical centers participating in either the Modification of Diet in Renal Disease (MDRD) Study or the Diabetes Control and Complications Trial (DCCT). GRF was measured as the renal clearance of [125I]iothalamate after an sc injection without epinephrine. The studies used similar protocols for obtaining blood and urine, training clinical center staff, and processing specimens in central laboratories. The performance of GFR measurements, assessed from adherence to protocol and quality control analyses, was excellent. The variability among the four clearance periods (intratest coefficient of variation [CV]) was acceptable; the median intratest CV for GFR was 9.4% in the MDRD Study and 11.7% in the DCCT. The pattern of decline in serum counts was better approximated by an exponential rather than a linear relationship. The cause of the intratest variability in GFR measurements was explored by univariate and multivariate analysis. The intratest CV was highest at the extremes of GFR. Among patients with a high GFR (> 90 mL/min per 1.73 m2), most of whom were participants in the DCCT, the higher intratest GFR was due, in part, to a systematic decline in GFR during the test. Among patients with a very low GFR (< 13 mL/min per 1.73 m2), technical difficulties in urine collections contributed substantially to the higher intratest CV. Other patient characteristics, including age, gender, weight, serum glucose, renal diagnosis, and use of diuretics, were not strongly correlated with the intratest CV. The precision of GFR measurements was assessed from the variability from measurement to measurement (interest CV). Among MDRD Study subjects, in whom two measurements of GFR were performed over a 3- month interval, the median interest CV was relatively low (6.3%) and was only weakly related to the intratest CV. Thus, GFR measurements are reasonably precise, even if the intratest CV is high. Given the relatively high intratest CV that is characteristic of GFR measurements, the estimate of GFR in an individual is more precise if multiple clearance periods, rather than a single period, are included. Similarly, the estimate of mean GFR for a population is also more precise if multiple clearance periods are included. In conclusion, by the use of standardized methods, an acceptable precision of GFR results can be obtained in multicenter trials. The same methods can be applied in clinical practice.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				C. H. Fox, A. Swanson, L. S. Kahn, K. Glaser, and B. M. Murray Improving Chronic Kidney Disease Care in Primary Care Practices: An Upstate New York Practice-based Research Network (UNYNET) Study J Am Board Fam Med, November 1, 2008; 21(6): 522 - 530. [Abstract] [Full Text] [PDF]

				N. D. Toussaint, K. K. Lau, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease Nephrol. Dial. Transplant., February 1, 2008; 23(2): 586 - 593. [Abstract] [Full Text] [PDF]

				V. Menon, M. G. Shlipak, X. Wang, J. Coresh, T. Greene, L. Stevens, J. W. Kusek, G. J. Beck, A. J. Collins, A. S. Levey, et al. Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease Ann Intern Med, July 3, 2007; 147(1): 19 - 27. [Abstract] [Full Text] [PDF]

				I. H. de Boer, S. D. Sibley, B. Kestenbaum, J. N. Sampson, B. Young, P. A. Cleary, M. W. Steffes, N. S. Weiss, J. D. Brunzell, and for the Diabetes Control and Complications Trial/E Central Obesity, Incident Microalbuminuria, and Change in Creatinine Clearance in the Epidemiology of Diabetes Interventions and Complications Study J. Am. Soc. Nephrol., January 1, 2007; 18(1): 235 - 243. [Abstract] [Full Text] [PDF]

				L. A. Stevens, J. Coresh, T. Greene, and A. S. Levey Assessing kidney function--measured and estimated glomerular filtration rate. N. Engl. J. Med., June 8, 2006; 354(23): 2473 - 2483. [Full Text] [PDF]

				M. P Pai, R.-C. Mercier, and S. E Allen Using Vancomycin Concentrations for Dosing Daptomycin in a Morbidly Obese Patient with Renal Insufficiency Ann. Pharmacother., March 1, 2006; 40(3): 553 - 558. [Abstract] [Full Text] [PDF]

				G. L. Myers, W. G. Miller, J. Coresh, J. Fleming, N. Greenberg, T. Greene, T. Hostetter, A. S. Levey, M. Panteghini, M. Welch, et al. Recommendations for Improving Serum Creatinine Measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program Clin. Chem., January 1, 2006; 52(1): 5 - 18. [Abstract] [Full Text] [PDF]

				J. Balla The Issue of Renal Safety of Zoledronic Acid from a Nephrologist's Point of View Oncologist, May 1, 2005; 10(5): 306 - 308. [Full Text] [PDF]

				H. Ibrahim, M. Mondress, A. Tello, Y. Fan, J. Koopmeiners, and W. Thomas An Alternative Formula to the Cockcroft-Gault and the Modification of Diet in Renal Diseases Formulas in Predicting GFR in Individuals with Type 1 Diabetes J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1051 - 1060. [Abstract] [Full Text] [PDF]

				J. Lewis, T. Greene, L. Appel, G. Contreras, J. Douglas, J. Lash, R. Toto, F. Van Lente, X. Wang, J. T. Wright Jr., et al. A Comparison of Iothalamate-GFR and Serum Creatinine-Based Outcomes: Acceleration in the Rate of GFR Decline in the African American Study of Kidney Disease and Hypertension J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3175 - 3183. [Abstract] [Full Text] [PDF]

				Writing Team for the Diabetes Control and Complica Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study JAMA, October 22, 2003; 290(16): 2159 - 2167. [Abstract] [Full Text] [PDF]

				B. Mackinnon, M. Boulton-Jones, and K. McLaughlin Analgesic-associated nephropathy in the West of Scotland: a 12-year observational study Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1800 - 1805. [Abstract] [Full Text] [PDF]

				I. Mpio, M. Laville, A. Hadj-Aissa, and J.-P. Fauvel Predicted creatinine clearance to evaluate glomerular filtration rate in black Caribbean subjects Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1307 - 1310. [Abstract] [Full Text] [PDF]

				C. Castaneda, P. L. Gordon, K. L. Uhlin, A. S. Levey, J. J. Kehayias, J. T. Dwyer, R. A. Fielding, R. Roubenoff, and M. F. Singh Resistance Training To Counteract the Catabolism of a Low-Protein Diet in Patients with Chronic Renal Insufficiency: A Randomized, Controlled Trial Ann Intern Med, December 4, 2001; 135(11): 965 - 976. [Abstract] [Full Text] [PDF]

				A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, D. Roth, and for the Modification of Diet in Renal Disease Stud A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation Ann Intern Med, March 16, 1999; 130(6): 461 - 470. [Abstract] [Full Text] [PDF]

				H. Braden, S. Cheema-Dhadli, C. D. Mazer, D. J. McKnight, W. Singer, and M. L. Halperin Hyperglycemia During Normothermic Cardiopulmonary Bypass: The Role of the Kidney Ann. Thorac. Surg., June 1, 1998; 65(6): 1588 - 1593. [Abstract] [Full Text] [PDF]

				L. A. Hebert, J. W. Kusek, T. Greene, L. Y. Agodoa, C. A. Jones, A. S. Levey, J. A. Breyer, P. Faubert, H. A. Rolin, and S.-R. Wang Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites Hypertension, September 1, 1997; 30(3): 428 - 435. [Abstract] [Full Text]

				S. Klahr, A. S. Levey, G. J. Beck, A. W. Caggiula, L. Hunsicker, J. W. Kusek, G. Striker, and The Modification of Diet in Renal Disease Study Gr The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease N. Engl. J. Med., March 31, 1994; 330(13): 877 - 884. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673